1256244-64-0

Basic information

• Product Name: (5Z)-5-(4-tert-butoxybenzylidene)imidazolidine-2,4-dione
• Synonyms: (5Z)-5-(4-tert-butoxybenzylidene)imidazolidine-2,4-dione
• CAS NO: 1256244-64-0
• Molecular Weight: 260.293
• Mol File: 1256244-64-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (5Z)-5-(4-tert-butoxybenzylidene)imidazolidine-2,4-dione(CAS DataBase Reference)
• NIST Chemistry Reference: (5Z)-5-(4-tert-butoxybenzylidene)imidazolidine-2,4-dione(1256244-64-0)
• EPA Substance Registry System: (5Z)-5-(4-tert-butoxybenzylidene)imidazolidine-2,4-dione(1256244-64-0)

Safety Data

• Hazardous Substances Data: 1256244-64-0(Hazardous Substances Data)

Upstream product

• 461-72-3 2,4-imidazolidinedione 
• 57699-45-3 p-tert-butoxybenzaldehyde 

Relevant articles and documents

Anti-cancer hydantoin compounds and methods

The present invention relates to methods of either treating or preventing cancer and novel compositions relevant to that treatment and prevention. More particularly, this invention relates to compounds which share features with (Z)-5-(4-hydroxybenzylidene)imidazolidine-2,4-dione and (Z)-5-(4-S-ethylbenzylidene)imidazolidine-2,4-dione and anti-cancer uses for those compounds. Embodiments of the present invention include methods that have anti-cancer effects including anti-metastatic, anti-growth, and anti-invasive activities.

Phenylmethylene hydantoins as prostate cancer invasion and migration inhibitors. CoMFA approach and QSAR analysis

Prostrate cancer constitutes the second leading cause of cancer deaths in men in United States. In the process of discovery of new antiproliferative and anti-metastatic agents against prostate cancer, marine-derived phenylmethylene hydantoin (PMH) derivatives were identified with activity level range between 50 and 200 μM. 3D-QSAR CoMFA model was used in virtual screening of commercially available derivatives of PMH. PMH derivatives with manifold increase in anti-migratory and anti-invasive activities were discovered using wound-healing and Cultrex invasion assays. Benzene ring replacement with other heterocyclic rings did not significantly improve the methylene hydantoins activities. Multivariate analysis performed on the whole series of methylene hydantoins, which further supported the findings of CoMFA model. Predictive QSAR model with conventional r2 and cross-validated coefficient (q 2) values up to 0.982 and 0.803 were established. The molecular volume (MV) and the log P were identified as critical parameters for methylene hydatoins migration inhibitory activity. PMH is a novel anti-metastatic lead class with potential therapeutic activity against prostate cancer.